Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China flag China · Delayed Price · Currency is CNY
12.82
-0.31 (-2.36%)
Nov 18, 2026, 3:00 PM CST

SHA:605266 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8,6518,9219,2839,0817,5145,235
Revenue Growth
-4.90%-3.90%2.23%20.84%43.54%17.21%
Gross Profit
2,9353,1953,2903,2362,6851,862
Operating Income
25.28368.73324.7639.62546.65386.78
Net Income
-211.26148.15128.13414.41374.29300.53
Earnings Per Share
-1.421.000.832.682.472.15
EPS Growth
-20.48%-69.03%8.65%14.74%-1.58%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Pharmaceutical Retail and Services
8,488
Convenience Sales Section
410.79
Wholesale Sales
10.29
Others
11.47
Total
8,921

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
883.86878.58826.05907.93935.6983.1
Total Debt
4,3034,2794,3423,6962,9351,282
Net Cash (Debt)
-3,419-3,400-3,516-2,788-1,999-298.88
Net Cash Growth
------
Net Cash Per Share
-23.06-22.95-22.78-18.03-13.17-2.14

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,0071,170508.981,0241,191744.4
Capital Expenditures
-75.98-144.56-267.92-300.04-780.68-385.53
Free Cash Flow
931.241,025241.05724.37409.93358.87
Free Cash Flow Growth
42.22%325.36%-66.72%76.71%14.23%95.50%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
33.93%35.82%35.44%35.64%35.73%35.57%
Operating Margin
0.29%4.13%3.50%7.04%7.27%7.39%
Pretax Margin
-2.31%2.32%1.82%5.76%5.87%6.84%
Profit Margin
-2.44%1.66%1.38%4.56%4.98%5.74%
FCF Margin
10.76%11.49%2.60%7.98%5.46%6.86%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.2701.2701.1001.0710.9360.777
Dividend Per Share Growth
15.45%15.46%2.73%14.41%20.51%-10.98%
Dividend Yield
9.91%6.61%4.70%2.16%1.82%2.06%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-19.2228.2118.4721.2117.71
Forward PE
-7.067.7616.5321.4115.69
P/FCF Ratio
2.042.7814.9910.5719.3714.83
PS Ratio
0.220.320.390.841.061.02